Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.05.2024 | Case report

Multiple drugs

Bullous pemphigoid and lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Hansen I, et al. Successful treatment of checkpoint inhibitor-associated bullous pemphigoid with dupilumab in a patient with angiosarcoma. Journal der Deutschen Dermatologischen Gesellschaft 22 : 587-589, No. 4, Apr 2024. Available from: URL: https://dx.doi.org/10.1111/ddg.15340 Hansen I, et al. Successful treatment of checkpoint inhibitor-associated bullous pemphigoid with dupilumab in a patient with angiosarcoma. Journal der Deutschen Dermatologischen Gesellschaft 22 : 587-589, No. 4, Apr 2024. Available from: URL: https://dx.doi.org/10.1111/ddg.15340
Metadaten
Titel
Multiple drugs
Bullous pemphigoid and lack of efficacy
Publikationsdatum
01.05.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-58316-8

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Phenylephrine

Case report

Tozinameran

Case report

Pembrolizumab

Case report

Prednisone